• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

正常受试者和特发性生长激素缺乏症患者对持续输注人胰腺生长激素释放因子1-44的反应。

The response of normal subjects and patients with idiopathic growth hormone deficiency to continuous infusion of human pancreatic growth hormone releasing factor 1-44.

作者信息

Davies R R, Turner S J, Parkin J M, Johnston D G

出版信息

Clin Endocrinol (Oxf). 1984 Nov;21(5):569-74. doi: 10.1111/j.1365-2265.1984.tb01396.x.

DOI:10.1111/j.1365-2265.1984.tb01396.x
PMID:6437706
Abstract

The GH response to a prolonged continuous infusion of human pancreatic growth hormone releasing factor (hpGRF 1-44), 0.3 microgram/kg/h was evaluated in seven patients with severe idiopathic GH deficiency, one patient with partial deficiency and in seven normal controls. Normal controls had a multiphasic response with a first peak between 15 and 90 min of 13.6 to 88.5, mean 45.6 mU/l and a second peak between 105 and 195 min of 8.8 to 73.1, mean 33.8 mU/l. However, the magnitude and pattern of response were highly variable. Six of the seven patients with severe GH deficiency had a response with a maximum level between 30 and 90 min of 3.3 to 7.5, mean 4.8 mU/l. Mean levels remained greater than 2.0 mU/l throughout the infusion but further peaks were absent or minimal. The patient with partial GH deficiency responded in a normal manner. hpGRF 1-44 by continuous infusion thus induced GH release in seven of eight patients with idiopathic GH deficiency though the response was impaired and the pattern of secretion abnormal in severely deficient patients.

摘要

对7例严重特发性生长激素缺乏症患者、1例部分生长激素缺乏症患者以及7名正常对照者,评估了生长激素对持续输注0.3微克/千克/小时人胰腺生长激素释放因子(hpGRF 1-44)的反应。正常对照者的反应呈多相性,第一个峰值出现在15至90分钟之间,为13.6至88.5,平均45.6 mU/l,第二个峰值出现在105至195分钟之间,为8.8至73.1,平均33.8 mU/l。然而,反应的幅度和模式差异很大。7例严重生长激素缺乏症患者中有6例的反应峰值出现在30至90分钟之间,为3.3至7.5,平均4.8 mU/l。在整个输注过程中,平均水平保持高于2.0 mU/l,但没有进一步的峰值或峰值极小。部分生长激素缺乏症患者的反应正常。因此,持续输注hpGRF 1-44可诱导8例特发性生长激素缺乏症患者中的7例释放生长激素,尽管严重缺乏症患者的反应受损且分泌模式异常。

相似文献

1
The response of normal subjects and patients with idiopathic growth hormone deficiency to continuous infusion of human pancreatic growth hormone releasing factor 1-44.正常受试者和特发性生长激素缺乏症患者对持续输注人胰腺生长激素释放因子1-44的反应。
Clin Endocrinol (Oxf). 1984 Nov;21(5):569-74. doi: 10.1111/j.1365-2265.1984.tb01396.x.
2
Effects of human pancreatic tumour growth hormone releasing factor on growth hormone and somatomedin C levels in patients with idiopathic growth hormone deficiency.人胰腺肿瘤生长激素释放因子对特发性生长激素缺乏症患者生长激素和生长调节素C水平的影响。
Lancet. 1983 Jul 16;2(8342):119-24. doi: 10.1016/s0140-6736(83)90113-7.
3
The interaction of human pancreatic growth hormone releasing factor 1-44 with somatostatin in vivo in normal man.人胰腺生长激素释放因子1 - 44与生长抑素在正常人体内的体内相互作用。
Clin Endocrinol (Oxf). 1985 Sep;23(3):271-6. doi: 10.1111/j.1365-2265.1985.tb00223.x.
4
Stimulation of growth hormone (GH) and somatomedin C in idiopathic GH-deficient subjects by intermittent pulsatile administration of synthetic human pancreatic tumor GH-releasing factor.
J Clin Endocrinol Metab. 1984 Jul;59(1):1-6. doi: 10.1210/jcem-59-1-1.
5
[The effect of synthetic human pancreatic growth hormone-releasing factor (hpGRF-44) on serum growth hormone response in normal and obese subjects].[合成人胰生长激素释放因子(hpGRF - 44)对正常和肥胖受试者血清生长激素反应的影响]
Nihon Naibunpi Gakkai Zasshi. 1986 Feb 20;62(2):82-96. doi: 10.1507/endocrine1927.62.2_82.
6
Growth hormone responsiveness to human pancreatic growth hormone releasing factor in acromegaly: modulatory effects of basal hormone levels and of concomitant somatostatin administration.肢端肥大症患者中生长激素对人胰腺生长激素释放因子的反应性:基础激素水平及同时给予生长抑素的调节作用
Clin Endocrinol (Oxf). 1984 Dec;21(6):701-7. doi: 10.1111/j.1365-2265.1984.tb01412.x.
7
The response of obese subjects to continuous infusion of human pancreatic growth hormone-releasing factor 1-44.肥胖受试者对持续输注人胰生长激素释放因子1 - 44的反应。
Clin Endocrinol (Oxf). 1985 Nov;23(5):521-5. doi: 10.1111/j.1365-2265.1985.tb01112.x.
8
Human pancreatic growth hormone-releasing factor (hpGRF-44) in acromegaly before and after adenomectomy. Modifications induced by somatostatin (GHRIH) infusion.肢端肥大症患者腺瘤切除前后的人胰腺生长激素释放因子(hpGRF - 44)。生长抑素(GHRIH)输注引起的变化。
J Endocrinol Invest. 1985 Oct;8(5):449-53. doi: 10.1007/BF03348536.
9
Oral glucose inhibits growth hormone secretion induced by human pancreatic growth hormone releasing factor 1-44 in normal man.口服葡萄糖可抑制正常人体内由人胰腺生长激素释放因子1 - 44诱导的生长激素分泌。
Clin Endocrinol (Oxf). 1984 Oct;21(4):477-81. doi: 10.1111/j.1365-2265.1984.tb03235.x.
10
Radiation and neuroregulatory control of growth hormone secretion.
Clin Endocrinol (Oxf). 1994 Aug;41(2):163-8. doi: 10.1111/j.1365-2265.1994.tb02525.x.

引用本文的文献

1
Synthetic growth hormone-releasing hormone (GHRH 1-44) in the differential diagnosis between hypothalamic and pituitary GH deficiency.合成生长激素释放激素(GHRH 1-44)在下丘脑性和垂体性生长激素缺乏症的鉴别诊断中的应用
J Endocrinol Invest. 1986 Dec;9(6):503-6. doi: 10.1007/BF03346976.
2
Growth hormone releasing hormone (GH-RH, GRF)--an important new clinical tool.
Eur J Pediatr. 1986 Apr;145(1-2):6-9. doi: 10.1007/BF00441843.
3
Regulation of growth hormone secretion in man: a review.人类生长激素分泌的调节:综述
J R Soc Med. 1985 Apr;78(4):319-27. doi: 10.1177/014107688507800410.